Responses
Oncolytic and local immunotherapy
Original research
Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
